>> 全站文章索引 >> 第9页:
  • Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects - [Isabelle Loubinoux, Jérémie Pariente, Olivier Rascol, Pierre Celsis and Fran?ois Chollet]
  • Effects of Sodium Valproate on Corticotropin-Releasing Factor Systems in Rat Brain - [Steven C Stout Ph.D, Michael J Owens Ph.D, Kimberly P Lindsey BS, David L Knight BS and Charles B Nemeroff MD, Ph.D]
  • Neurobehavioral Effects of Interferon- in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions - [Lucile Capuron1 Ph.D, Jane F Gumnick1 MD, Dominique L Musselman1,2 MD, David H Lawson2 MD, Andrea Reemsnyder1 BS, Charles B Nemeroff1,2 MD, Ph.D and Andrew H Miller1,2 MD]
  • Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors - [Miki Yamauchi, Takako Miyara, Tetsuya Matsushima and Taiichiro Imanishi]
  • 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary–adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity - [Michael T. Williams, Tori L. Schaefer, Lisa A. Ehrman, Jessica A. Able, Gary A. Gudelsky, Renu Sah and Charles V. Vorhees]
  • Serotonin Reuptake Is Less Efficient in Taste Aversion Resistant Than in Taste Aversion-Prone Rats - [R. L. Elkins, T. E. Orr, J. Q. Li, P. A. Walters, J. L. Whitford, G. F. Carl and J. L. Rausch]
  • Nicotine exposure during pregnancy is a factor which influences serotonin transporter density in the rat brain - [Katsumasa Muneoka, Tetsuo Ogawa, Kenji Kamei, Yuichi Mimura, Hitomi Kato and Morikuni Takigawa]
  • Acute and repeated administration of fluoxetine, citalopram, and paroxetine significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study - [Yoshimoto Sekine 1, Katsuaki Suzuki 1, P. Veeraraghavan Ramachandran 2, Thomas P. Blackburn 3, Charles R. Ashby JR. 4 * AD:1Department of Psychiatry and Neurology, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan2Department of Chemistry]
  • Differential effect of dietary selenium on the long-term neurotoxicity induced by MDMA in mice and rats - [V. Sanchez, J. Camarero, E. O’Shea, A. R. Green and M. I. Colado]
  • Daily fatigue in women with osteoarthritis, rheumatoid arthritis, and fibromyalgia and fibromyalgia - [Zautra AJ, Fasman R, Parish BP, Davis MC.]
  • The frequency of thyroid antibodies in fibromyalgia patients and their relationship with symptoms - [Pamuk ON, Cakir N.]
  • Intracerebroventricular infusion of leptin decreases serotonin transporter binding sites in the frontal cortex of the rat - [Yves Charnay, Isabelle Cusin, Philippe G. Vallet, Patrick Muzzin, Fran?oise Rohner-Jeanrenaud and Constantin Bouras]
  • Comparison of Six Depression Rating Scales in Geriatric Stroke Patients - [Agrell, Berit M.; Dehlin, Ove M.]
  • Sexual Function and Dysfunction in Brazilian Patients With Obsessive-Compulsive Disorder and Social Anxiety Disorder - [Fontenelle LF, de Souza WF, de Menezes GB, Mendlowicz MV, Miotto RR, Falc?o R, Versiani M, Figueira IL.]
  • Citalopram treatment of paroxetine-intolerant depressed patients - [Michael E. Thase, M.D. 1 *, James M. Ferguson, M.D. 2, R. Bruce Lydiard, M.D., Ph.D. 3, Charles S. Wilcox, Ph.D. 4 AD:1Department of Psychiatry University of Pittsburgh School of Medicine, Western Psychiatric Institute Clinic, Pittsburgh, Pennsylvania2Pha]
  • Penetrating the blind in a study of an SSRI - [Melissa P. Piasecki, David O. Antonuccio, Gerri M. Steinagel, Barbara S. Kohlenberg and Karen Kapadar]
  • Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential - [Chien-Jung Huang, Alec Harootunian, Michael P Maher, Catherine Quan, Christopher D Raj, Ken McCormack, Randal Numann, Paul A Negulescu & Jesús E González]
  • Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone - [Zo? A. Hughes, Kathryn R. Starr, Christopher J. Langmead, Matthew Hill, Gerd D. Bartoszyk, James J. Hagan, Derek N. Middlemiss and Lee A. Dawson]
  • Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Tayoshi-Shibuya, Sawako Kinouchi, Masahito Nakataki, Hongwei Song, Kazuhiko Hokoishi, Hirotaka Tanabe, et al.]
  • Preferential 5-HT1A Autoreceptor Occupancy by Pindolol is Attenuated in Depressed Patients: Effect of Treatment or an Endophenotype of Depression? - [Eugenii A Rabiner1,2, Zubin Bhagwagar2,3, Roger N Gunn1,4, Philip J Cowen3 and Paul M Grasby2]
  • Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis - [Isabelle Malagié, Antoine Deslandes and Alain M. Gardier]
  • 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA in rat brain: pharmacological manipulation - [Yukihiko Shirayama, Kenji Hashimoto, Masaomi Iyo, Kei-ichiro Watanabe, Teruhiko Higuchi and Yoshio Minabe]
  • HAB/LAB rats: an animal model of extremes in trait anxiety and depression - [Rainer Landgraf]
  • Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites - [Jean-Claude Bé?que *, Claude De Montigny, Pierre Blier, Guy Debonnel AD:Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montréal, Québec, Canada]
  • Social anxiety, depressive symptoms, and post-event reminationaffective consequences and social contextual influences - [Kashdan TB, Roberts JE.]
  • Solubility of paroxetine hydrochloride hemi-hydrate in (water + acetone) - [Guobin Ren, Jingkang Wang and Guizhi Li]
  • 7,7,8,8-Tetracyanoquinodimethane as a new derivatization reagent for high-performance liquid chromatography and thin-layer chromatography: rapid screening of plasma for some antidepressants - [Aysel Oztunc, Armagan Onal and S?d?ka Erturk]
  • Minor Depression After Stroke - [Paradiso, Sergio M.; Robinson, Robert G.]
  • Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA ('Ecstasy') in Rats - [Murray R Thompson1, Kong M Li2, Kelly J Clemens1, Clint G Gurtman1, Glenn E Hunt3, Jennifer L Cornish1 and Iain S McGregor1]
  • Social anxiety spectrum and diminished positive experiences-Theoretical synthesis and meta-analysis - [Kashdan TB.]
  • British panel bans use of antidepressant to treat children - [Alison Abbott]
  • Dysregulation of tau phosphorylation is hypothesized point of convergence in the pathogenesis of alzheimer's disease,frontotemporal dementia and schizophrenia with therapeutic implications - [Deutsch SI, Rosse RB, Lakshman RM.]
  • An investigation of the long-term benefits of antidepressant medication in the recovery of patients with chronic fatigue syndrome - [Thomas MA, Smith AP.]
  • Chronic Effects of Triiodothyronine in Combination with Imipramine on 5-HT Transporter, 5-HT1A and 5-HT2A Receptors in Adult Rat Brain - [X Moreau Ph.D, R Jeanningros Ph.D and P Mazzola-Pomietto Ph.D]
  • Trimipramine for Refractory Panic Attacks - [Domingo Cerra]
  • Effect of nortriptyline and paroxetine on measures of chaos of heart rate time series in patients with panic disorder - [Vikram Kumar Yeragani and Radhakrishna Rao]
  • Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients - [David C Mamo, Bruce G Pollock, Benoit Mulsant, Patricia R Houck, et al.]
  • A retrospective cohort study of diabetes and antipsychotic treatment in the United States - [Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L.]
  • Subchronic Administration of Fluoxetine Impairs Estrous Behavior in Intact Female Rats - [Josefa Vega Matuszczyk1 Ph.D, Knut Larsson1 Ph.D and Elias Eriksson2 Ph.D]
  • Buried Data Can Be HazardousTo a Company’s Health - [Eliot Marshall]
  • Panorama: The Secrets of Seroxat - [P J Cowen]
  • DRUGS AS MATERIALS: VALUING PHYSICAL FORM IN DRUG DISCOVERY - [Colin R. Gardner, Christopher T. Walsh & ?rn Almarsson about the authors]
  • The neurobiology of itch - [Akihiko Ikoma1, Martin Steinhoff2, Sonja St?nder3, Gil Yosipovitch4 and Martin Schmelz5 About the authors]
  • Entry order as a consideration for innovation strategies - [Fredric J. Cohen1 About the author]
  • Nature Reviews Neuroscience 7, 278-294 (April 2006) | doi:10.1038/nrn1886 - [Ageing and neuronal vulnerabilityMark P. Mattson1,2 and Tim Magnus1 About the authors]
  • Drug interactions in cancer therapy - [Charity D. Scripture1 and William D. Figg1 About the authors]
  • A comparison of in vivo and in vitro neuroimaging of 5-HT1A receptor binding sites in the cat brain - [Nicolas Aznavour, Latifa Rbah, Lucienne Léger, Colette Buda, Jean-Pierre Sastre, Anouk Imhof, Yves Charnay and Luc Zimmer]
  • Aggression, Impulsivity, and Central Nervous System Serotonergic Responsivity in a Nonpatient Sample - [Stephen B Manuck1 Ph.D, Janine D Flory1 Ph.D, Jeanne M McCaffery1 BA, Karen A Matthews3 Ph.D, J John Mann4 MD and Matthew F Muldoon2 MD, MPH]
  • Improved efficacy of fluoxetine in increasing hippocampal 5-hydroxytryptamine outflow in 5-HT1B receptor knock-out mice - [Isabelle Malagié, Denis J. David, Pascale Jolliet, René Hen, Michel Bourin and Alain M. Gardier]
  • Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test? - [Caroline E. Renard, Eric Dailly, Bríd á. Nic Dhonnchadha, Martine Hascoet and Michel Bourin]
  • Pilot evaluation of paroxetine for treating hot flashes in men. - [Loprinzi CL, Barton DL, Carpenter LA, Sloan JA, Novotny PJ, Gettman MT, Christensen BJ]
  • Selective Serotonin Reuptake Inhibitors, Fluoxetine and Paroxetine, Attenuate the Expression of the Established Behavioral Sensitization Induced by Methamphetamine - [Yujiro Kaneko1, Atsushi Kashiwa1, Takashi Ito1, Sumikazu Ishii1, Asami Umino1 and Toru Nishikawa1]
  • Alterations in Central Neuropeptide Expression, Release, and Receptor Binding in Rats Bred for High Anxiety: Critical Role of Vasopressin - [Alexandra Wigger1, Mar M Sánchez2, Kenneth C Mathys2, Karl Ebner3, Elisabeth Frank1, Dong Liu1, Adelheid Kresse4, Inga D Neumann5, Florian Holsboer1, Paul M Plotsky2 and Rainer Landgraf1]
  • Vasopressin Mediates the Response of the Combined Dexamethasone/CRH Test in Hyper-anxious Rats: Implications for Pathogenesis of Affective Disorders - [Martin E Keck MD, Alexandra Wigger Ph.D, Tobias Welt BSc, Marianne B Muller MD, Angela Gesing Ph.D, Johannes M H M Reul Ph.D, Florian Holsboer MD, Ph.D, Rainer Landgraf Ph.D and Inga D Neumann Ph.D]
  • Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development - [Xu Y, Sari Y, Zhou FC.]
  • Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development - [Yanling Xu, Youssef Sari and Feng C. Zhou]
  • Impact of Comorbidity on Treatment Response to Paroxetine in Pediatric Obsessive-Compulsive Disorder: Is the Use of Exclusion Criteria EmpiricallySupported in Randomized Clinical Trials? - [Daniel A. Geller, Joseph Biederman, S. Evelyn Stewart, Benjamin Mullin, Colleen Farrell, Karen Dineen Wagner, Graham]
  • Effects of subchronic paroxetine administration on night-time endocrinological profiles in healthy male volunteers - [R. Schl?sser, H. Wetzel, H. D?rr, W. Rossbach, Ch. Hiemke and O. Benkert]
  • Sleep Laboratory Study on Single and Repeated Dose Effects of Paroxetine, Alprazolam and Their Combination in Healthy Young Volunteers - [Manuel J. Barbanoj, Susana Clos, Sergio Romero, Adelaida Morte, Sandra Giménez, José L. Lorenzo, Antonio Luque,]
  • A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder. - [Kasper S, Olivieri L, Di Loreto G, Dionisio P]
  • Differences in compliance patterns across the selective serotonin reuptake inhibitors (SSRIs). - [Keene MS, Eaddy MT, Mauch RP, Regan TS, Shah M, Chiao E]
  • Mixed anxiety-depression in a primary-care clinic - [Stein MB, Kirk P, Prabhu V, Grott M, Terepa M.]
  • Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain - [C. Vilpoux, I. Leroux-Nicollet, L. Naudon, R. Raisman-Vozari and J. Costentin]
  • A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder - [Mark H. Pollack, M.D. 1 *, Ulla Lepola, M.D. 2, Hannu Koponen, M.D. 3, Naomi M. Simon, M.D. 1, John J. Worthington, M.D. 1, Gerard Emilien, Ph.D. 4, Evan Tzanis, B.A. 5, Eliseo Salinas, M.D. 5, Timothy Whitaker, M.D. 5, Bo Gao, Ph.D. 5 AD:1Massachusetts G]
  • The association between panic disorder and the L/L genotype of catechol-O-methyltransferase - [Jong-Min Woo, Kyung-Sik Yoon, Young-Hee Choi, Kang-Sub Oh, Young-Sik Lee and Bum-Hee Yu]
  • Effect of paroxetine on a model of posttraumatic stress disorder in rats - [Takehito Sawamura, Kunio Shimizu, Masashi Nibuya, Tomoki Wakizono, Go Suzuki, Tomoya Tsunoda, Yoshitomo Takahashi and Soichiro Nomura]
  • Platelet serotonin and [3H]paroxetine binding correlate with recurrence of suicidal behavior - [R. J. Verkes, Durk Fekkes, Aeilko H. Zwinderman, Michiel W. Hengeveld, Rose C. Van der Mast, Jolien P. Tuyl, Ad. J. F. M. Kerkhof, Godfried M. J. Van Kempen]
  • State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine - [H Murck, T Nickel, H Künzel, I A Antonijevic, J Schill, A Zobel, A Steiger, A Sonntag, F Holsboer]
  • Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study - [Jean Pierre Lepine 1 *, Carlo Altamura 2, Marc Ansseau 3, Jose Luis Ayuso Gutierrez 4, Istvan Bitter 5, Malcolm Lader 6, Lionel Waintraub 7 * AD:1Service de Psychiatrie, H魀ital Fernand Widal, 200, rue du Faubourg St Denis, 75745 Paris Cedex 10, France2Un]
  • Sertraline, Paroxetine, and Venlafaxine in Refugee Posttraumatic Stress Disorder with Depression Symptoms - [Amer Smajkic, Stevan Weine, Zvezdana Djuric-Bijedic, Esad Boskailo, Jonathan Lewis, Ivan Pavkovic]
  • Setting New Standards for the Pharmacological Treatment of Panic Disorder - [R. KUMAR * AD:SmithKline Beecham Pharmaceuticals, New Frontiers Science Park (South), Third Avenue, Harlow, Essex CM19 5AW, UK]
  • ACNP Task Force Report on SSRIs and Suicidal Behavior in Youth - [.]
  • Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. - [Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I]
  • Phencyclidine-Induced Cognitive Deficits in Mice are Improved by Subsequent Subchronic Administration of Fluvoxamine: Role of Sigma-1 Receptors - [Kenji Hashimoto1, Yuko Fujita1 and Masaomi Iyo2]
  • Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression - [Martin M Katz, Janet L Tekell, Charles L Bowden, Steve Brannan, John P Houston, Nancy Berman, Alan Frazer]
  • The effect of changes in depression on health related quality of life (HRQoL) in HIV infection - [Andrew J. Elliott, Joan Russo and Peter P. Roy-Byrne]
  • In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously - [S W Kim, S H Lee, J-S Paick]
  • Symptom presentation and classroom functioning in a nonclinical sample of children with social phobia - [Bernstein GA, Bernat DH, Davis AA, Layne AE.]
  • Symptom presentation and classroom functioning in a nonclinical sample of children with social phobia - [Bernstein GA, Bernat DH, Davis AA, Layne AE.]
  • Effects of acute treatment with paroxetine,citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow:a microdialysis study in Swiss mice1 - [D J P David, M Bourin, G Jego, C Przybylski, P Jolliet, A M Gardier]
  • The Kutcher Generalized Social Anxiety Disorder Scale for Adolescents: Assessment of its Evaluative Properties Over the Course of a - [Sarah J. Brooks, Stan Kutcher]
  • Chronic prenatal exposure to paroxetine (Paxil) and cognitive development of mice offspring - [H. Dix Christensen, William F. Rayburn and Christina L. Gonzalez]
  • Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro - [C. Lass-Florl, M. P. Dierich, D. Fuchs, E. Semenitz, I. Jenewein, M. Ledochowski]
  • Effects of Fluoxetine on the Polysomnogram in Outpatients with Major Depression - [Madhukar H Trivedi1 MD, A John Rush1 MD, Roseanne Armitage1 Ph.D, Christina M Gullion1 Ph.D, Bruce D Grannemann1 MA, Paul J Orsulak1 Ph.D and Howard P Roffwarg2 MD]
  • Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring - [Zhuo Chen, Kate Waimey, Louis D. Van de Kar, Gonzalo A. Carrasco, Michelle Landry and George Battaglia]
  • Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder - [V. K. Yeragani, R. B. Pohl, V. C. Jampala, R. Balon, C. Ramesh and K. Srinivasan 472.]
  • Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder - [Vikram K. Yeragani, M.B.B.S. 1 2 3 *, Robert Pohl, M.D. 1, V.C. Jampala, M.B.B.S. 2, Richard Balon, M.D. 1, C. Ramesh, M.D. 1, K. Srinivasan, M.D. 4 AD:1Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan2Veterans Affair]
  • Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells - [Gunter Kenis, Harry Steinbusch, Marc De Baets and Michael Maes]
  • D2 dopamine receptor gene polymorphism: paroxetine and social functioning in posttraumatic stress disorder - [Bruce R. Lawford, , Ross McD. Young, Ernest P. Noble, Burnett Kann, Leanne Arnold, John Rowell and Terry L. Ritchie]
  • Post-Stroke Depression Relationships to Functional Impairment, Coping Strategies, and Rehabilitation Outcome. - [Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H.]
  • Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT2C receptor responsivity - [E. J. Bull, P. H. Hutson and K. C. F. Fone]
  • Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity - [Eleanor J. Bull, Peter H. Hutson and Kevin C. F. Fone]
  • Screening for Depression in Stroke Patients: The Reliability and Validity of the Center for Epidemiologic Studies Depression Scale - [SHINAR, D. AVID; GROSS, C. YNTHIA; PRICE, T. HOMAS; BANKO, M. ARYANN; BOLDUC, P. AULA; ROBINSON, R. OBERT]
  • Course of depression in patients with comorbid anxiety disorders - [Sherbourne CD, Wells KB.]
  • The effects of cognitive behavior therapy on depression in older patients with cardiovascular risks - [Strachowski D, Khaylis A, Conrad A, Neri E, Spiegel D, Taylor CB.]
  • Coping with rheumatoid arthritis pain in daily life- Within-person analyses reveal hidden vulnerability for the formerly depressed - [Conner TS, Tennen H, Zautra AJ, Affleck G, Armeli S, Fifield J]
  • A controlled trial of paroxetine for chronic PTSD, dissociation, and interpersonal problems in mostly minority adults - [Randall D. Marshall, M.D. *, Roberto Lewis-Fernandez, M.D., Carlos Blanco, M.D., Ph.D., H. Blair Simpson, M.D., Ph.D., Shu-Hsing Lin, Ph.D., Donna Vermes, M.S.N.P.P., Wendy Garcia, B.A., Franklin Schneier, M.D., Yuval Neria, Ph.D., Arturo Sanchez-Lacay, M]
  • Effects of olanzapine on aggressiveness in heroin dependent patients - [G. Gerra, G. Di Petta, A. D'Amore, P. Iannotta, F. Bardicchia, F. Falorni, A. Coacci, G. Strepparola, G. Campione, A. Lucchini, et al.]
  • Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: A pharmacological characterization of diverse classes of antidepressant agents - [Mauricette Brocco, Anne Dekeyne, Sylvie Veiga, Sylvie Girardon and Mark J. Millan]
  • Paroxetine treatment of generalized anxiety disorder: A double-blind, placebo-controlled study - [Karl Rickels, Rocco Zaninelli, James McCafferty, Kevin Bellew, et al]


    • 分页: 1 2 3 4 5 6 7 8 [9] 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50